A randomized prospective study of laser ablation of the prostate versus transurethral resection of the prostate in men with benign prostatic hyperplasia

被引:37
|
作者
Shingleton, WB [1 ]
Terrell, F [1 ]
Renfroe, DL [1 ]
Kolski, JM [1 ]
Fowler, JE [1 ]
机构
[1] Univ Mississippi, Sch Med, Div Urol, Jackson, MS 39216 USA
关键词
D O I
10.1016/S0090-4295(99)00319-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives, To compare the safety and efficacy of laser ablation of the prostate, one of the minimally invasive treatments available for men with benign prostatic hyperplasia, to transurethral resection of the prostate (TURP). Methods. A prospective randomized study of 100 men with benign prostatic hyperplasia, with 50 patients in each:treatment arm, was conducted. All patients met the entry criteria: age older than 45 years, no history of carcinoma of the prostate, a peak flow rate less than 15 mL/s, medical therapy failure, and the ability to undergo regional or general anesthesia. All patients underwent a preoperative evaluation consisting of the American Urological Association (AUA) symptom score, uroflowmetry, pressure-flow study, transrectal ultrasound for prostate volume, and serum prostate-specific antigen determination. Patients underwent either TURF or laser ablation of the prostate using the potassium titanyl phosphate (KTP)/neodymium: yttrium-aluminum-garnet laser. Patients were seen for follow-up at 1, 3, 6, and 12 months. Results. The mean age was 68.2 years (range 45 to 90) for the laser group and 67.4 years (range 54 to 82) for the TURP group. The mean AUA symptom score was 22 for the laser group and 21 for the TURF group. The mean peak uroflow rate was 7.6 +/- 3.4 mL/s for the laser group and 6.5 +/- 4.0 mL/s for the TURF group. At 12 months of follow-up, the mean AUA symptom score had decreased to 7 (-69.5%) for the laser group and to 3 (-80.9%) for the TURF group. The mean peak uroflow rate increased to 15.4 mL/s (+107.8%) for the laser group and to 16.7 mL/s (+150.7%) for the TURP cohort.:Seventy-five percent of the laser group had a 50% or greater decrease in their individual AUA symptom score compared with 93% of the TURF group. Sixty-five percent of the laser cohort had a 50% or greater increase in their peak uroflow rate compared: with 75% of the TURF cohort. Conclusions. Laser prostatectomy produced improvements in the peak flow rate and symptom score similar to those produced by TURF. The patients who underwent laser treatment required a longer period to reach maximum improvement, which probably reflects the lack of:tissue debulking at the time of surgery. Further improvement in laser technology will be required to produce more immediate results. (C) 1999, Elsevier Science Inc.
引用
收藏
页码:1017 / 1021
页数:5
相关论文
共 50 条
  • [31] Differences in stress response between patients undergoing transurethral resection versus endoscopic laser ablation of the prostate for benign prostatic hyperplasia
    Bedalov, Goran
    Bartolin, Zeljko
    Puskar, Damir
    Savic, Ivan
    Bedalov, Ivana
    Rudolf, Marija
    Batinic, Drago
    LASERS IN MEDICAL SCIENCE, 2008, 23 (01) : 65 - 70
  • [32] Prostatic Artery Embolization Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: A CostEffectiveness Analysis
    Wu, Xiao
    Zhou, Alice
    Heller, Michael
    Kohlbrenner, Ryan
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2022, 33 (12) : 1605 - 1615
  • [33] Three-year follow-up of laser prostatectomy versus transurethral resection of the prostate in men with benign prostatic hyperplasia
    Shingleton, WB
    Farabaugh, P
    May, W
    UROLOGY, 2002, 60 (02) : 305 - 308
  • [34] Holmium laser enucleation of the prostate vs monopolar transurethral resection of the prostate in management of benign prostatic hyperplasia
    Sayed, Salah
    Elshorbagy, Amr
    Mahmoud, Mahmoud A.
    Mostafa, Diaaeldin
    EGYPTIAN JOURNAL OF SURGERY, 2021, 40 (01): : 121 - 130
  • [35] A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia
    Bruskewitz, R
    Issa, MM
    Roehrborn, CG
    Naslund, MJ
    Perez-Marrero, R
    Shumaker, BP
    Oesterling, JE
    JOURNAL OF UROLOGY, 1998, 159 (05): : 1588 - 1593
  • [36] Comparison of Holmium Laser Enucleation of Prostate versus Bipolar Resection of Prostate in Patients with Benign Prostatic Hyperplasia: A Prospective Interventional Study
    Mulay, Abhirudra
    Ranjan, Pratyush
    Sabale, Vilas
    Bagla, Harsh
    Satav, Vikram
    Ghotankar, Shambhavi
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2024, 18 (09) : OC19 - OC22
  • [37] THULIUM: YAG LASER VAPORESECTION VERSUS BIPOLAR TRANSURETHRAL RESECTION OF THE PROSTATE FOR THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA: COMPARATIVE STUDY
    Rokba, Mohamed
    Selim, Mohamed
    Abdallh, Mohamed
    Elmahdy, Alaa
    Omr, Mohamed
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1223 - E1224
  • [38] Tamsulosin versus transurethral resection of the prostate: Effect on nocturia as a result of benign prostatic hyperplasia
    Simaioforidis, Vasileios
    Papatsoris, Athanasios G.
    Chrisofos, Michael
    Chrisafis, Manolis
    Koritsiadis, Sotirios
    Deliveliotis, Charalambos
    INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (03) : 243 - 248
  • [39] A MULTICENTER, RANDOMIZED, PROSPECTIVE-STUDY OF ENDOSCOPIC LASER-ABLATION VERSUS TRANSURETHRAL RESECTION OF THE PROSTATE
    ANSON, K
    NAWROCKI, J
    BUCKLEY, J
    FOWLER, C
    KIRBY, R
    LAWRENCE, W
    PATERSON, P
    WATSON, G
    UROLOGY, 1995, 46 (03) : 305 - 310
  • [40] Holmium laser enucleation of the prostate versus transurethral resection of the prostate in treatment of benign prostatic hyperplasia: A meta-analysis of 13 randomized control trials
    Daryanto, Besut
    Suryanullah, Wisnu Syahputra
    Putra, Probo Yudha Pratama
    CURRENT UROLOGY, 2025, 19 (01) : 6 - 16